Solasia Pharma KK (TSE:4597) Total Liabilities: 円284.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4597 Solasia Pharma KK TSE:4597
49 GF Score
Price 円27.00
GF Value 円2.42
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Solasia Pharma KK Total Liabilities?

Solasia Pharma KK TSE:4597 +3.85% 49 Total Liabilities is 円284.00 Mil as of Mar. 2026. GuruFocus rates TSE:4597 with a GF Score™ of 49/100 and a GF Value™ of 円2.42 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Solasia Pharma KK's Total Liabilities for the quarter that ended in Mar. 2026 was 円284.00 Mil.

Solasia Pharma KK's quarterly Total Liabilities declined from Sep. 2025 (円544.00 Mil) to Dec. 2025 (円458.00 Mil) and declined from Dec. 2025 (円458.00 Mil) to Mar. 2026 (円284.00 Mil).

Solasia Pharma KK's annual Total Liabilities declined from Dec. 2023 (円354.00 Mil) to Dec. 2024 (円321.00 Mil) but then increased from Dec. 2024 (円321.00 Mil) to Dec. 2025 (円458.00 Mil).

Solasia Pharma KK Total Liabilities Historical Data

* Premium members only.

The historical data trend for Solasia Pharma KK's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Solasia Pharma KK Total Liabilities Chart

Solasia Pharma KK Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 557.00 472.00 354.00 321.00 458.00

Solasia Pharma KK Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 463.00 588.00 544.00 458.00 284.00
TSE:4597
49GF Score
Solasia Pharma KK TSE:4597
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Solasia Pharma KK Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Solasia Pharma KK's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=414+(16+28
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=458.00

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=2078-1620
=458.00

Solasia Pharma KK's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=214+(55+15
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=284.00

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=1992-1708
=284.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of 円284.00 Mil mean?
Solasia Pharma KK (TSE:4597) has a Total Liabilities of 円284.00 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Solasia Pharma KK and its competitors.
Is Solasia Pharma KK's Total Liabilities too high?
Solasia Pharma KK's current Total Liabilities is 円284.00 Mil. Overall, Solasia Pharma KK has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Solasia Pharma KK's Total Liabilities compare to ZTS and UTHR?
Solasia Pharma KK's Total Liabilities of 円284.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Solasia Pharma KK and its competitors. Solasia Pharma KK's current Total Liabilities is 円284.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solasia Pharma KK stock overvalued right now?
Based on GuruFocus' analysis, Solasia Pharma KK (TSE:4597) is currently considered Significantly Overvalued. The stock's GF Value™ is 円2.42, compared to a current price of 円27.00 — trading 1015.7% above its estimated fair value. The current Total Liabilities is 円284.00 Mil. Solasia Pharma KK's overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Solasia Pharma KK (TSE:4597), the current Total Liabilities is 円284.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Solasia Pharma KK (TSE:4597) Overvalued in 2026?

Based on GuruFocus' analysis, Solasia Pharma KK stock appears to be overvalued. The current stock price of 円27.00 is trading 1015.7% above its estimated GF Value™ of 円2.42. GuruFocus considers Solasia Pharma KK to be Significantly Overvalued.

Key valuation signals for TSE:4597:

  • Total Liabilities: 円284.00 Mil
  • GF Value™: 円2.42 vs. price of 円27.00 (1015.7% above fair value)
  • GF Score™: 49/100 with 6 warning signs

No single metric tells the full story. See the TSE:4597 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Solasia Pharma KK Business Description

Other Exchanges 9SO:Germany
Address 2-1-1 Shiba Park, 4th Floor, Sumitomo Real Estate Shiba Park Tower, Minato-ku, Tokyo, JPN, 105-0011
Solasia Pharma KK develops and distributes pharmaceuticals and medical devices relating to malignant tumors.
49GF Score

Get the complete analysis for TSE:4597

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円27.00
Price
円2.42
GF Value